KLOW combines GHK-Cu, BPC-157, TB-500 and KPV in a broad experimental formulation spanning tissue response, extracellular matrix, skin biology and barrier-signalling research.
- Composition
- GHK-Cu 50 mg + BPC-157 10 mg + TB-500 10 mg + KPV 10 mg
- Presentation
- 80 mg / 3 mL
- Research focus
- Tissue response · Barrier signalling · Extracellular matrix · Skin biology

